340 related articles for article (PubMed ID: 9797793)
21. Efficacy of three statins at lower maintenance doses.
Carr-Lopez S; Exstrum T; Morse T; Shepherd M; Bush AC
Clin Ther; 1999 Feb; 21(2):331-9. PubMed ID: 10211536
[TBL] [Abstract][Full Text] [Related]
22. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
Varis T; Kivistö KT; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
24. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
Black AE; Sinz MW; Hayes RN; Woolf TF
Drug Metab Dispos; 1998 Aug; 26(8):755-63. PubMed ID: 9698289
[TBL] [Abstract][Full Text] [Related]
26. No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran.
Sarich TC; Schützer KM; Dorani H; Wall U; Kalies I; Ohlsson L; Eriksson UG
J Clin Pharmacol; 2004 Aug; 44(8):928-34. PubMed ID: 15286097
[TBL] [Abstract][Full Text] [Related]
27. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
[TBL] [Abstract][Full Text] [Related]
28. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin.
Pan HY; Triscari J; DeVault AR; Smith SA; Wang-Iverson D; Swanson BN; Willard DA
Br J Clin Pharmacol; 1991 Jun; 31(6):665-70. PubMed ID: 1907839
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
Neuvonen PJ; Backman JT; Niemi M
Clin Pharmacokinet; 2008; 47(7):463-74. PubMed ID: 18563955
[TBL] [Abstract][Full Text] [Related]
31. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
[TBL] [Abstract][Full Text] [Related]
32. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
[TBL] [Abstract][Full Text] [Related]
33. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
34. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Baner K; Benet LZ; Sewing KF; Christians U
J Pharmacol Exp Ther; 1999 Oct; 291(1):131-9. PubMed ID: 10490896
[TBL] [Abstract][Full Text] [Related]
35. Effect of multiple cilostazol doses on single dose lovastatin pharmacokinetics in healthy volunteers.
Bramer SL; Brisson J; Corey AE; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():69-77. PubMed ID: 10702889
[TBL] [Abstract][Full Text] [Related]
36. Effect of fluconazole on plasma fluvastatin and pravastatin concentrations.
Kantola T; Backman JT; Niemi M; Kivistö KT; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Jun; 56(3):225-9. PubMed ID: 10952477
[TBL] [Abstract][Full Text] [Related]
37. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone.
Varis T; Backman JT; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623
[TBL] [Abstract][Full Text] [Related]
38. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; Vyas KP; Kari PH; MacDonald JS
J Pharmacol Exp Ther; 1991 Jun; 257(3):1225-35. PubMed ID: 1904494
[TBL] [Abstract][Full Text] [Related]
39. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
Niemi M; Pasanen MK; Neuvonen PJ
Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
[TBL] [Abstract][Full Text] [Related]
40. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid.
Kantola T; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Apr; 63(4):397-402. PubMed ID: 9585793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
